XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	19,300	19,600	21.12.
	19,300	19,500	20.12.

Realtime

Geld

Brief

Zeit

19,300

19,600

21.12.

19,300

19,500

20.12.

XFRA CAPITAL ADJUSTMENT INFORMATION - 10.01.2024

Das Instrument SCT GB0007908733 SSE PLC LS-,50 EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2024 und ex Kapitalmassnahme am 11.01.2024
The instrument SCT GB0007908733 SSE PLC LS-,50 EQUITY is traded cum capital adjustment on 10.01.2024 and ex capital adjustment on 11.01.2024

Das Instrument 329 AU000000CXX3 CRADLE RESOURCES LTD EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2024 und ex Kapitalmassnahme am 11.01.2024
The instrument 329 AU000000CXX3 CRADLE RESOURCES LTD EQUITY is traded cum capital adjustment on 10.01.2024 and ex capital adjustment on 11.01.2024

Das Instrument 1P50 US70387R4039 PAVMED INC. DL -,001 EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2024 und ex Kapitalmassnahme am 11.01.2024
The instrument 1P50 US70387R4039 PAVMED INC. DL -,001 EQUITY is traded cum capital adjustment on 10.01.2024 and ex capital adjustment on 11.01.2024

Das Instrument 89P SE0005308558 CLAVISTER HOLDING AB EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2024 und ex Kapitalmassnahme am 11.01.2024
The instrument 89P SE0005308558 CLAVISTER HOLDING AB EQUITY is traded cum capital adjustment on 10.01.2024 and ex capital adjustment on 11.01.2024

Das Instrument 8W5 SE0007692124 VIDHANCE AB O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2024 und ex Kapitalmassnahme am 11.01.2024
The instrument 8W5 SE0007692124 VIDHANCE AB O.N. EQUITY is traded cum capital adjustment on 10.01.2024 and ex capital adjustment on 11.01.2024

Das Instrument EBE DE000A2G8XP9 AIFINYO AG INH O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2024 und ex Kapitalmassnahme am 11.01.2024
The instrument EBE DE000A2G8XP9 AIFINYO AG INH O.N. EQUITY is traded cum capital adjustment on 10.01.2024 and ex capital adjustment on 11.01.2024

Das Instrument 9RV GB00B8YZTJ80 VERSARIEN PLC LS -,001 EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2024 und ex Kapitalmassnahme am 11.01.2024
The instrument 9RV GB00B8YZTJ80 VERSARIEN PLC LS -,001 EQUITY is traded cum capital adjustment on 10.01.2024 and ex capital adjustment on 11.01.2024

6 Richtige für 2025

Das Börsenjahr 2025 klopft schon an die Tür – und wie immer geht es um die Frage: Welche Aktien werden die großen Gewinner sein? Die Auswahl an Möglichkeiten ist riesig, doch nur ein paar echte Volltreffer stechen heraus.

Ob stabiler Dividenden-Lieferant, Tech-Pionier oder spekulative Wette im Krypto-Bereich – wir haben die Märkte für Sie ausgiebig durchforstet und präsentieren Ihnen 6 Unternehmen, die große Chancen auf außergewöhnliche Kurssteigerungen besitzen. Hier sind, speziell für Sie, Ihre „6 Richtigen“ für 2025.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche Unternehmen das Potenzial besitzen, im kommenden Jahr richtig durchzustarten!

Hier klicken

Zeit	Aktuelle Nachrichten
02.10.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2024		The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2024ISIN NameCA38149V2021 GOLDHAVEN... ► Artikel lesen
02.10.	XETR DELETION OF INSTRUMENTS FROM XETRA - 02.10.2024		The following instruments on XETRA do have their last trading day on 02.10.2024Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 02.10.2024ISIN NameDE000A3EX2X7 aifinyo AG ► Artikel lesen

Zeit

Aktuelle Nachrichten

02.10.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2024

The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2024ISIN NameCA38149V2021 GOLDHAVEN...
► Artikel lesen

02.10.

XETR DELETION OF INSTRUMENTS FROM XETRA - 02.10.2024

The following instruments on XETRA do have their last trading day on 02.10.2024Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 02.10.2024ISIN NameDE000A3EX2X7 aifinyo AG
► Artikel lesen

Zeit	Aktuelle Nachrichten
07.11.	Clavister Holding AB: Clavister Q3 2024: Positive Operating Profit (EBIT)	November 7, 2024, Örnsköldsvik, Sweden. Clavister, a leader in European cybersecurity for mission-critical applications released its latest quarterly report for 2024. Positive Operating Profit (EBIT)Net... ► Artikel lesen
22.08.	Clavister Holding AB: Clavister Q2 2024: 17 % Net Sales Growth	August 22, 2024, Örnsköldsvik, Sweden. Clavister, a leader in European cybersecurity for mission-critical applications released its latest quarterly report for 2024. Net Sales adjusted for currency... ► Artikel lesen
15.02.	Nasdaq Stockholm AB: New equity rights for trading, Clavister Holding AB (74/24)	At the request of Clavister Holding AB, Clavister Holding AB equity rights TO 8 will be traded on First North Growth Market as from February 16, 2024. Security name: Clavister Holding AB TO 8 ----------------------------------------- Short... ► Artikel lesen
15.01.	Nasdaq Stockholm AB: Listing of subscription units and paid subscription units of Clavister Holding AB (23/24)	With effect from January 16, 2024, the subscription units in Clavister Holding AB will be traded on First North Growth Market. Trading will continue up until and including January 25, 2024. Instrument:... ► Artikel lesen
10.01.	XFRA CAPITAL ADJUSTMENT INFORMATION - 10.01.2024	Das Instrument SCT GB0007908733 SSE PLC LS-,50 EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2024 und ex Kapitalmassnahme am 11.01.2024 The instrument SCT GB0007908733 SSE PLC LS-,50 EQUITY is... ► Artikel lesen

Zeit

Aktuelle Nachrichten

07.11.

Clavister Holding AB: Clavister Q3 2024: Positive Operating Profit (EBIT)

November 7, 2024, Örnsköldsvik, Sweden. Clavister, a leader in European cybersecurity for mission-critical applications released its latest quarterly report for 2024. Positive Operating Profit (EBIT)Net...
► Artikel lesen

22.08.

Clavister Holding AB: Clavister Q2 2024: 17 % Net Sales Growth

August 22, 2024, Örnsköldsvik, Sweden. Clavister, a leader in European cybersecurity for mission-critical applications released its latest quarterly report for 2024. Net Sales adjusted for currency...
► Artikel lesen

15.02.

Nasdaq Stockholm AB: New equity rights for trading, Clavister Holding AB (74/24)

At the request of Clavister Holding AB, Clavister Holding AB equity rights TO 8 will be traded on First North Growth Market as from February 16, 2024. Security name: Clavister Holding AB TO 8 ----------------------------------------- Short...
► Artikel lesen

15.01.

Nasdaq Stockholm AB: Listing of subscription units and paid subscription units of Clavister Holding AB (23/24)

With effect from January 16, 2024, the subscription units in Clavister Holding AB will be traded on First North Growth Market. Trading will continue up until and including January 25, 2024. Instrument:...
► Artikel lesen

10.01.

XFRA CAPITAL ADJUSTMENT INFORMATION - 10.01.2024

Zeit	Aktuelle Nachrichten
12.12.	Road to 2025: Earths Energy's geothermal evolution
29.11.	EARTHS ENERGY LIMITED: Change of Director's Interest Notice
29.11.	EARTHS ENERGY LIMITED: Notification regarding unquoted securities - EE1
27.11.	EARTHS ENERGY LIMITED: Results of Meeting
26.11.	EARTHS ENERGY LIMITED: Final Director's Interest Notice

Zeit

Aktuelle Nachrichten

12.12.

Road to 2025: Earths Energy's geothermal evolution

29.11.

EARTHS ENERGY LIMITED: Change of Director's Interest Notice

29.11.

EARTHS ENERGY LIMITED: Notification regarding unquoted securities - EE1

27.11.

EARTHS ENERGY LIMITED: Results of Meeting

26.11.

EARTHS ENERGY LIMITED: Final Director's Interest Notice

Zeit	Aktuelle Nachrichten
29.11.	PAVmed Inc. - 8-K, Current Report
21.11.	PAVmed Inc. - 8-K, Current Report
14.11.	PAVmed Non-GAAP EPS of -$0.54 beats by $0.76, revenue of $0.99M misses by $0.1M
14.11.	PAVmed Inc.: PAVmed Provides Business Update and Third Quarter 2024 Financial Results	Lucid reports record quarterly EsoGuard® revenue and completes clinical evidence package for imminent submission to formally seek Medicare coverage Veris Health... ► Artikel lesen
14.11.	PAVmed Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

29.11.

PAVmed Inc. - 8-K, Current Report

21.11.

PAVmed Inc. - 8-K, Current Report

14.11.

PAVmed Non-GAAP EPS of -$0.54 beats by $0.76, revenue of $0.99M misses by $0.1M

14.11.

PAVmed Inc.: PAVmed Provides Business Update and Third Quarter 2024 Financial Results

Lucid reports record quarterly EsoGuard® revenue and completes clinical evidence package for imminent submission to formally seek Medicare coverage Veris Health...
► Artikel lesen

14.11.

PAVmed Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
Fr	SSE's outlook revised lower at S&P Global due to high investment, ratings affirmed
Di	SSE reaches FID on 208MW Strathy South: SSE reaches FID on 208MW Strathy South
Di	SSE toasts first power from 101MW Irish wind farm: SSE toasts first power from 101MW Irish wind farm
11.12.	SSE's transmission business sets out plans to invest at least £22bn in mission-critical grid infrastructure
10.12.	SSE outlines £22B investment plan to boost Scotland's grid

Zeit

Aktuelle Nachrichten

SSE's outlook revised lower at S&P Global due to high investment, ratings affirmed

SSE reaches FID on 208MW Strathy South: SSE reaches FID on 208MW Strathy South

SSE toasts first power from 101MW Irish wind farm: SSE toasts first power from 101MW Irish wind farm

11.12.

SSE's transmission business sets out plans to invest at least £22bn in mission-critical grid infrastructure

10.12.

SSE outlines £22B investment plan to boost Scotland's grid

Zeit	Aktuelle Nachrichten
13.12.	Versarien subsidiary awarded EUR 0.8m grant
13.12.	Three Quick Facts: Tullow, Chapel Down, Versarien
13.12.	Versarien PLC - €804,000 Grant Award
12.12.	Versarien PLC - Investor Webinar Recording
09.12.	Versarien enters graphene biosensor distribution deal

Zeit

Aktuelle Nachrichten

13.12.

Versarien subsidiary awarded EUR 0.8m grant

13.12.

Three Quick Facts: Tullow, Chapel Down, Versarien

13.12.

Versarien PLC - €804,000 Grant Award

12.12.

Versarien PLC - Investor Webinar Recording

09.12.

Versarien enters graphene biosensor distribution deal

Zeit	Aktuelle Nachrichten
11.01.	XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 11.01.2024		The following instruments on XETRA do have their first trading 11.01.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 11.01.2024 Aktien 1 IT0005577090 Cloudia Research S.p.A. 2... ► Artikel lesen
10.01.	XFRA CAPITAL ADJUSTMENT INFORMATION - 10.01.2024		Das Instrument SCT GB0007908733 SSE PLC LS-,50 EQUITY wird cum Kapitalmassnahme gehandelt am 10.01.2024 und ex Kapitalmassnahme am 11.01.2024 The instrument SCT GB0007908733 SSE PLC LS-,50 EQUITY is... ► Artikel lesen

Zeit

Aktuelle Nachrichten

11.01.

XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 11.01.2024

The following instruments on XETRA do have their first trading 11.01.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 11.01.2024 Aktien 1 IT0005577090 Cloudia Research S.p.A. 2...
► Artikel lesen

10.01.

XFRA CAPITAL ADJUSTMENT INFORMATION - 10.01.2024

Unternehmen / Aktien	Kurs	%
AIFINYO AG	3,100	0,00 %
CLAVISTER HOLDING AB	0,165	-23,13 %
EARTHS ENERGY LIMITED	0,002	0,00 %
PAVMED INC	1,000	0,00 %
SSE PLC	19,500	+0,52 %
VERSARIEN PLC	0,001	0,00 %
VIDHANCE AB	0,504	-12,50 %

Unternehmen / Aktien

Kurs

AIFINYO AG

3,100

0,00 %

CLAVISTER HOLDING AB

0,165

-23,13 %

EARTHS ENERGY LIMITED

0,002

0,00 %

PAVMED INC